Cargando…

Dried Plasma

Dried plasma provides an alternative for early plasma transfusion in the resuscitation of hemorrhagic shock in environments where fresh frozen plasma is not immediately available. It is produced by freeze-drying or spray-drying liquid or thawed plasma. It is shelf-stable for prolonged periods, can b...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaza, Mouayyad, Kalkwarf, Kyle J., Holcomb, John B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123378/
http://dx.doi.org/10.1007/978-3-030-20820-2_8
_version_ 1783515624761196544
author Zaza, Mouayyad
Kalkwarf, Kyle J.
Holcomb, John B.
author_facet Zaza, Mouayyad
Kalkwarf, Kyle J.
Holcomb, John B.
author_sort Zaza, Mouayyad
collection PubMed
description Dried plasma provides an alternative for early plasma transfusion in the resuscitation of hemorrhagic shock in environments where fresh frozen plasma is not immediately available. It is produced by freeze-drying or spray-drying liquid or thawed plasma. It is shelf-stable for prolonged periods, can be stored at room temperature, and is easy to transport, reconstitute, and administer. It was widely used in WWII but fell out of favor due to the risk of infectious disease transmission. The German and French experiences with lyophilized plasma are the most extensive and show a good track record of efficacy and safety. Recent studies show many beneficial effects of dried plasma in the treatment of shock in large animal models. Currently, no FDA-licensed product is available in the USA, but several are under development.
format Online
Article
Text
id pubmed-7123378
institution National Center for Biotechnology Information
language English
publishDate 2019
record_format MEDLINE/PubMed
spelling pubmed-71233782020-04-06 Dried Plasma Zaza, Mouayyad Kalkwarf, Kyle J. Holcomb, John B. Damage Control Resuscitation Article Dried plasma provides an alternative for early plasma transfusion in the resuscitation of hemorrhagic shock in environments where fresh frozen plasma is not immediately available. It is produced by freeze-drying or spray-drying liquid or thawed plasma. It is shelf-stable for prolonged periods, can be stored at room temperature, and is easy to transport, reconstitute, and administer. It was widely used in WWII but fell out of favor due to the risk of infectious disease transmission. The German and French experiences with lyophilized plasma are the most extensive and show a good track record of efficacy and safety. Recent studies show many beneficial effects of dried plasma in the treatment of shock in large animal models. Currently, no FDA-licensed product is available in the USA, but several are under development. 2019-05-06 /pmc/articles/PMC7123378/ http://dx.doi.org/10.1007/978-3-030-20820-2_8 Text en © Springer Nature Switzerland AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Zaza, Mouayyad
Kalkwarf, Kyle J.
Holcomb, John B.
Dried Plasma
title Dried Plasma
title_full Dried Plasma
title_fullStr Dried Plasma
title_full_unstemmed Dried Plasma
title_short Dried Plasma
title_sort dried plasma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123378/
http://dx.doi.org/10.1007/978-3-030-20820-2_8
work_keys_str_mv AT zazamouayyad driedplasma
AT kalkwarfkylej driedplasma
AT holcombjohnb driedplasma